Skip to main content
Springer logoLink to Springer
. 2025 Apr 21;149(1):34. doi: 10.1007/s00401-025-02877-4

Correction: CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease

Juan Lantero-Rodriguez 1,, Laia Montoliu-Gaya 1, Andrea L Benedet 1, Agathe Vrillon 2, Julien Dumurgier 2, Emmanuel Cognat 2, Wagner S Brum 1,3, Nesrine Rahmouni 4,5, Jenna Stevenson 4,5, Stijn Servaes 4,5, Joseph Therriault 4,5, Bruno Becker 1, Gunnar Brinkmalm 1, Anniina Snellman 1,6, Hanna Huber 1, Hlin Kvartsberg 1,7, Nicholas J Ashton 1,8,9,10, Henrik Zetterberg 1,7,11,12,13,14, Claire Paquet 2, Pedro Rosa-Neto 4,5, Kaj Blennow 1,7
PMCID: PMC12011925  PMID: 40257474

Correction: Acta Neuropathologica (2024) 147:12 10.1007/s00401-023-02659-w

In this article, the following sentence with the term serine 205 was incorrectly published in the section Materials and methods under the subsection Simoa CSF p‑tau202 and p‑tau205 measurements:

Similarly, in the CSF p-tau205 immunoassay, a rabbit polyclonal antibody selective against phosphorylated tau at serine 205 (immunogen: synthesized human tau peptide around the phosphorylation site of serine205, ThermoFisher Scientific) was used as capture antibody with biotinylated Tau12 used for detection.

The correct term should be threonine 205, and the correct sentence should be as given below:

Similarly, in the CSF p-tau205 immunoassay, a rabbit polyclonal antibody selective against phosphorylated tau at threonine 205 (immunogen: synthesized human tau peptide around the phosphorylation site of threonine205, ThermoFisher Scientific) was used as capture antibody with biotinylated Tau12 used for detection.

Now, the original has been corrected.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Acta Neuropathologica are provided here courtesy of Springer

RESOURCES